Baldwin Insurance Group

BWIN · NASDAQ

$31.89+$0.02 (+0.06%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $31.87

BWIN analyst rating

BuyConsensus of 10 analysts over the last 12 months. 40% rate it a buy.

Strong buy1
Buy3
Hold6
Underperform0
Sell0

12-month price target · 10 analysts

Average $34.07 (+6.8% upside)

Low: $27.50
Now: $31.89
High: $39.90

Upgrades and downgrades

The latest rating actions, newest first

BWIN analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
TD Cowen	Oct 12, 2026	Downgrade	Buy → Hold	$37.00 → $32.50	54%
UBS	Oct 2, 2026	Downgrade	Buy → Neutral	$37.00 → $32.50	68%
JP Morgan	Oct 1, 2026	Downgrade	Overweight → Neutral	$30.00 → $32.00	81%
BMO Capital	Sep 15, 2026	Maintains	Market Perform	$26.00 → $32.50	45%
William Blair	Sep 14, 2026	Downgrade	Outperform → Market Perform	—	67%
UBS	Aug 3, 2026	Maintains	Buy	$35.00 → $37.00	68%
Wells Fargo	Aug 3, 2026	Maintains	Equal-Weight	$27.00 → $28.00	60%
JP Morgan	Jul 13, 2026	Maintains	Overweight	$28.00 → $30.00	81%
Wells Fargo	Jul 9, 2026	Maintains	Equal-Weight	$24.00 → $27.00	60%
Keefe, Bruyette & Woods	Jul 8, 2026	Maintains	Outperform	$26.00 → $31.00	68%

The case for and against

Updated Jan 26, 2026

Bull case

Baldwin Insurance Group, Inc. has demonstrated strong growth through a rapid pace of acquisitions, which has significantly expanded its market presence and product offerings. Despite elevated financial leverage resulting from these acquisitions, the company shows potential for long-term value creation through its diversified insurance products, including business insurance and benefits consulting. Overall, the strategic expansion into various segments positions Baldwin Insurance favorably within the competitive landscape, suggesting a resilient business model.

Bear case

Baldwin Insurance's stock outlook is negatively influenced by its high debt levels, which may prompt rating agencies to consider downgrades if the company's organic growth does not keep pace with its peers. Additionally, changing macroeconomic conditions pose a risk to demand for the company's services and could lead to depressed pricing, further threatening financial results. Moreover, regulatory risks associated with the marketing of Medicare plans may increase operational expenses and contribute to potential losses in market share and earnings.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.